Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 4995-4996

  Hillenbrand, M ^a   Bastian, M ^a   Steiner, M ^a   Zingler, C H ^a   Muller M ^a   Wolff, J M ^a   Seiter, H ^a   Schuff Werner, P ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Benign prostatic hyperplasia; Prostate cancer; Prostate specific antigen; Serum to urinary ratio

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; BENIGN TUMOR; CANCER SCREENING; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; SERUM; URINALYSIS;

AGED; HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0034450599     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Extraprostatic production of prostate specific antigen is under hormonal control
2. Urinary prostate specific antigen levels: Role in monitoring the response of prostate cancer to therapy
3. Serum-to-urinary prostate-specific antigen ratio: A potential means of distinguishing benign prostatic hyperplasia from prostate cancer
4. Inflammation in benign prostatic hyperplasia: Correlation with prostate specific antigen value
5. Serum-to-urine prostate specific antigen ratio: Its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng/ml
6. An analysis of urinary prostate specific antigen, before and after radical prostatectomy: Evidence for secretion of prostate specific antigen by the periurethral glands
7. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesical protein
8. High concentrations of prostate specific antigen in urine of women receiving oral contraceptives
9. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer
10. Elimination kinetics of prostate-specific antigen serum and urine
11. Technical and physiological aspects of PSA estimation in urine
12. Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer
13. Purification of a human prostate specific antigen